ES2053055T3 - Proceso para la preparacion de un medicamento endermico con una base de gel. - Google Patents

Proceso para la preparacion de un medicamento endermico con una base de gel.

Info

Publication number
ES2053055T3
ES2053055T3 ES90121083T ES90121083T ES2053055T3 ES 2053055 T3 ES2053055 T3 ES 2053055T3 ES 90121083 T ES90121083 T ES 90121083T ES 90121083 T ES90121083 T ES 90121083T ES 2053055 T3 ES2053055 T3 ES 2053055T3
Authority
ES
Spain
Prior art keywords
ether
endermic
gel
cellulose
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90121083T
Other languages
English (en)
Inventor
Obara Sakae
Muto Hiroaki
Mizuno Sumiko
Chiba Thoru
Saitoh Izumi
Ikeda Kaori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shin Etsu Chemical Co Ltd
Shionogi and Co Ltd
Original Assignee
Shin Etsu Chemical Co Ltd
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Etsu Chemical Co Ltd, Shionogi and Co Ltd filed Critical Shin Etsu Chemical Co Ltd
Application granted granted Critical
Publication of ES2053055T3 publication Critical patent/ES2053055T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN NUEVO MEDICAMENTO ENDERMICO TIENE UNA CONSISTENCIA DE GEL, ESTE SE FORMULA COMO UNA BASE DE GEL CON ETER CELULOSA SOLUBLE AL AGUA NO-IONICO, P.E., METIL CELULOSA E HIDROPROPIL METIL CELULOSA, MODIFICADO CON UNA MODIFICACION QUE CONTIENE UN AGENTE, EN LA MOLECULA, QUE ES UN GRUPO ALKIL QUE TIENE DE 6 A 8 ATOMOS DE CARBONO Y UN GRUPO FUNCIONAL QUE TIENE REACTIVIDAD AL GRUPO HIDROXIL EN EL ETER CELULOSA, P.E., ETER GLICIDIL ESTEARIL, ETER GLICIDIL DECIL Y EPOXIDO CETIL. EL MEDICAMENTO ENDERMICO FORMULADO CON EL ETER CELULOSA MODIFICADO ES ESTABLE EN VIRTUD DE UNA PEQUEÑA INTERACCION ENTRE LOS INGREDIENTES ACTIVOS Y LA BASE DE GEL Y TAMBIEN PUEDE EXHIBIR UNA ALTA ABSORVENCIA PERCUTANEA DE LOS INGREDIENTES ACTIVOS A TRAVES DE LA PIEL HUMANA.
ES90121083T 1989-11-07 1990-11-03 Proceso para la preparacion de un medicamento endermico con una base de gel. Expired - Lifetime ES2053055T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1289241A JP2610052B2 (ja) 1989-11-07 1989-11-07 外用ゲル基剤

Publications (1)

Publication Number Publication Date
ES2053055T3 true ES2053055T3 (es) 1994-07-16

Family

ID=17740608

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90121083T Expired - Lifetime ES2053055T3 (es) 1989-11-07 1990-11-03 Proceso para la preparacion de un medicamento endermico con una base de gel.

Country Status (6)

Country Link
US (1) US5086077A (es)
EP (1) EP0427157B1 (es)
JP (1) JP2610052B2 (es)
KR (1) KR960008315B1 (es)
DE (1) DE69008117T2 (es)
ES (1) ES2053055T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2120305C1 (ru) * 1997-11-27 1998-10-20 Открытое акционерное общество Химико-фармацевтический комбинат "Акрихин" Фармацевтический состав, обладающий противогрибковой активностью, и способ его получения
JP2003252749A (ja) * 2002-03-04 2003-09-10 Shin Etsu Chem Co Ltd 外用基剤
TW200501952A (en) * 2003-02-21 2005-01-16 Shionogi & Co Pirfenidone gel formulations
US20080008745A1 (en) * 2006-06-21 2008-01-10 University Of Kentucky Research Foundation Transdermal delivery of naltrexone hydrochloride, naltrexol hydrochloride, and bis(hydroxy-methyl)propionyl-3-0 ester naltrexone using microneedles
EP2228052A1 (en) * 2009-03-09 2010-09-15 Coty Deutschland GmbH Cosmetic basic composition and use thereof
EP2620138B1 (en) * 2010-09-24 2016-12-07 Daido Chemical Corporation Foam-type external skin preparation
JP5954928B2 (ja) * 2010-11-19 2016-07-20 大同化成工業株式会社 皮膚潰瘍処置用外用剤のゲル状基剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2249523A (en) * 1939-03-31 1941-07-15 Eastman Kodak Co Medicament
JPS5993022A (ja) * 1982-11-16 1984-05-29 Kao Corp ポリオ−ルエ−テル化合物およびその製造法ならびにこれを含有する化粧料
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
JPS61244369A (ja) * 1985-04-23 1986-10-30 ライオン株式会社 吸水性粘着組成物
US4683004A (en) * 1985-08-20 1987-07-28 Union Carbide Corporation Foamable compositions and processes for use thereof
LU86202A1 (fr) * 1985-12-11 1987-07-24 Oreal Composition cosmetique pour la coloration de la peau renfermant de l'aldehyde mesotartrique et une ou plusieurs hydroxyquinones et procede de coloration de la peau avec cette composition

Also Published As

Publication number Publication date
US5086077A (en) 1992-02-04
KR960008315B1 (ko) 1996-06-24
JP2610052B2 (ja) 1997-05-14
DE69008117T2 (de) 1994-07-21
JPH03151330A (ja) 1991-06-27
KR910009244A (ko) 1991-06-28
EP0427157A3 (en) 1991-09-11
EP0427157B1 (en) 1994-04-13
EP0427157A2 (en) 1991-05-15
DE69008117D1 (de) 1994-05-19

Similar Documents

Publication Publication Date Title
US3891757A (en) Anaesthetic topical and percutaneous administration with selected promoters
Rosiak et al. Polyacrylamide hydrogels as sustained release drug delivery dressing materials
ES2121793T3 (es) Composiciones de uso local para la administracion transdermica de derivados profarmacos de morfina.
ES2177793T3 (es) Pañal que tiene unalamina superior con locion que comprende un emoliente liquido de tipo poliester de poliol y un agente inmovilizante.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ZA796651B (en) New amino-pyrimidine-carbanilides, processes for their preparation, medicaments containing these compounds and their use and also diamino-pyrimidinecarbanilides and processes for their preparation
ES2060138T3 (es) Esteres yodados.
US3968245A (en) Sympathomimetic topical and percutaneous administration with halogenated promoters
ES2132101T3 (es) Procedimiento para la preparacion de un medicamento destinado a la administracion por via oral o topica en el tratamiento de leishmaniasis.
NL190693C (nl) Stabiel, prostaglandine bevattend, farmaceutisch preparaat.
KR900017590A (ko) 좌창(Acne)치료방법 및 그 약제 조성물
BR0211968A (pt) Glicolipìdio útil no tratamento de doenças autoimunes e medicamento do mesmo
SE8303013L (sv) B-gamma-dihydropolyprenylalkoholderivat och farmaceutisk komposition innehallande en polyprenylforening
CA2229787A1 (en) Cosmetic gel composition having reduced skin irritation
PT95473A (pt) Processo para a preparacao de derivados de 24-homo-vitamina d e de composicoes farmaceuticas que os contem
ES2053055T3 (es) Proceso para la preparacion de un medicamento endermico con una base de gel.
FR2457689A1 (fr) Medicament hypolipemique a base de carnitine
KR840003415A (ko) 경구용 당뇨병 치료제의 제조방법
AR246160A1 (es) Preservativo para composiciones acuosas.
SE7610595L (sv) Forfarande for framstellning av en farmaceutisk komposition av insulinŸfor rektal anvendning
PT1305057E (pt) Composicao de biomateria microparticular para uso medicinal
ES2059130T3 (es) Composiciones farmaceuticas que contienen ipriflavona, procedimiento para su preparacion y uso terapeutico relacionado.
KR910015312A (ko) 소화·탈취 조성물
AR008858A1 (es) Preparados farmaceuticos que contienen derivados 1-hidroxi-2-(1h) piridona, procedimiento para su obtencion y empleo de los mismos para la preparacion deun medicamento para el tratamiento y profilaxis de micosis cutaneas.
EA199800218A1 (ru) Фармацевтический препарат с трипанозидными свойствами

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 427157

Country of ref document: ES